Effect of Artesunate on Peripheral Parasitaemia in Pregnant Women with Plasmodium Falciparum Infection

Effect of Artesunate on Peripheral Parasitaemia in Pregnant Women with Plasmodium Falciparum Infection

Objective: To determine the effect of artesunate on peripheral parasitaemia in pregnant women with Plasmodium falciparum infection. Methods: Pregnant women in second and third trimester with Plasmodium falciparum infection and their newborns were included in cohort prospective study in Sorong West...

Full description

Bibliographic Details
Main Authors:	Susi W Saragih, St. Maisuri T. Chalid, Umar Malinta, Isra Wahid
Format:	Article
Language:	English
Published:	Indonesian Society of Obstetrics and Gynecology 2017-11-01
Series:	Indonesian Journal of Obstetrics and Gynecology
Online Access:	http://inajog.com/index.php/journal/article/view/537

Similar Items

Recrudescence of a high parasitaemia, severe Plasmodium falciparum malaria episode, treated by artesunate monotherapy
by: Sophie Landre, et al.
Published: (2021-04-01)

Malaria parasitaemia and Plasmodium falciparum specific-IgG in maternal peripheral, placental and cord circulaton
by: C.C. Onyenekwe, O.G. Arinola, S.C. Meludu, L.S. Salimonu, I.F. Adewale & A.K. Obisesan
Published: (2004-09-01)

Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic <it>Plasmodium falciparum </it>infections in Kinshasa DRC
by: Wesche David, et al.
Published: (2011-02-01)

Literacy and recent history of diarrhoea are predictive of <it>Plasmodium falciparum </it>parasitaemia in Kenyan adults
by: Ofula Victor O, et al.
Published: (2006-11-01)

Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.
by: Myat P Kyaw, et al.
Published: (2013-01-01)

Dynamic deformability of Plasmodium falciparum-infected erythrocytes exposed to artesunate in vitro
by: Huang, Sha, et al.
Published: (2014)

Reduction in the proportion of fevers associated with <it>Plasmodium falciparum </it>parasitaemia in Africa: a systematic review
by: D'Acremont Valérie, et al.
Published: (2010-08-01)

Prevalence of <it>Plasmodium falciparum </it>infection in pregnant women in Gabon
by: Kendjo Eric, et al.
Published: (2003-06-01)

A simple and fast method to exclude high <it>Plasmodium falciparum </it>parasitaemia in travellers with imported malaria
by: Jacobs Jan, et al.
Published: (2011-10-01)

The Association of Creactive Protein Levels in Second Trimester of Pregnancy with Preeclampsia
by: Zulfaekasari Nasruddin, et al.
Published: (2018-01-01)

Artesunate Misuse and Plasmodium falciparum Malaria in Traveler Returning from Africa
by: Dea Shahinas, et al.
Published: (2010-10-01)

<it>In vivo</it> susceptibility of <it>Plasmodium falciparum</it> to artesunate in Binh Phuoc Province, Vietnam
by: Hien Tran, et al.
Published: (2012-10-01)

Spatial risk profiling of <it>Plasmodium falciparum </it>parasitaemia in a high endemicity area in Côte d'Ivoire
by: Yapi Ahoua, et al.
Published: (2009-11-01)

Blood-Stage Parasitaemia and Age Determine Plasmodium falciparum and P. vivax Gametocytaemia in Papua New Guinea.
by: Cristian Koepfli, et al.
Published: (2015-01-01)

Evidence of an increased incidence of day 3 parasitaemia in Suriname: an indicator of the emerging resistance of Plasmodium falciparum to artemether
by: Stephen GS Vreden, et al.
Published: (2013-12-01)

Prevalence of Plasmodium falciparum Parasitaemia and Its Correlation with Haematological Parameters among HIV-Positive Individuals in Nigeria
by: Olusola Ojurongbe, et al.
Published: (2014-01-01)

The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated <it>Plasmodium falciparum </it>malaria
by: Singhasivanon Pratap, et al.
Published: (2009-09-01)

Refractoriness of eryptotic red blood cells to Plasmodium falciparum infection: a putative host defense mechanism limiting parasitaemia.
by: Paulo Renato Rivas Totino, et al.
Published: (2011-01-01)

Bone marrow suppression and severe anaemia associated with persistent <it>Plasmodium falciparum </it>infection in African children with microscopically undetectable parasitaemia
by: Rodriques Onike, et al.
Published: (2005-12-01)

Artesunate-amodiaquine fixed dose combination for the treatment of <it>Plasmodium falciparum </it>malaria in India
by: Anvikar Anupkumar R, et al.
Published: (2012-03-01)

Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan
by: Ahmed Elderderi S, et al.
Published: (2005-09-01)

Plasmodium falciparum gametocyte dynamics after pyronaridine–artesunate or artemether–lumefantrine treatment
by: Johanna M. Roth, et al.
Published: (2018-06-01)

Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname
by: Vreden SGS, et al.
Published: (2016-11-01)

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial [version 2; peer review: 2 approved]
by: Sofia Birgersson, et al.
Published: (2020-01-01)

A case of blackwater fever with persistent Plasmodium falciparum parasitaemia detected by PCR after artemether–lumefantrine treatment
by: Paul John Huggan, et al.
Published: (2018-01-01)

Impact of Submicroscopic Plasmodium falciparum Parasitaemia on Maternal Anaemia and Low Birth Weight in Blue Nile State, Sudan
by: Samia A. Omer, et al.
Published: (2019-01-01)

A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan.
by: Badria El-Sayed, et al.
Published: (2007-12-01)

Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy
by: Aminatou Kone, et al.
Published: (2020-06-01)

Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated <it>Plasmodium falciparum </it>malaria
by: Quezada Wilmer, et al.
Published: (2009-04-01)

Failure of artesunate-mefloquine combination therapy for uncomplicated <it>Plasmodium falciparum </it>malaria in southern Cambodia
by: Muth Sinuon, et al.
Published: (2009-01-01)

High prevalence of very-low Plasmodium falciparum and Plasmodium vivax parasitaemia carriers in the Peruvian Amazon: insights into local and occupational mobility-related transmission
by: Gabriel Carrasco-Escobar, et al.
Published: (2017-10-01)

Increased Sensitivity of Plasmodium falciparum to Artesunate/Amodiaquine Despite 14 Years as First-Line Malaria Treatment, Zanzibar
by: Mwinyi Msellem, et al.
Published: (2020-08-01)

Plasmodium falciparum infection in pregnant women attending antenatal care in Luanda, Angola
by: Paulo Adão Campos, et al.
Published: (2012-06-01)

Placental Microparticles and MicroRNAs in Pregnant Women with Plasmodium falciparum or HIV Infection.
by: Laura Moro, et al.
Published: (2016-01-01)

Prevalence of afebrile parasitaemia due to Plasmodium falciparum & P. vivax in district Balaghat (Madhya Pradesh): Implication for malaria control
by: Neha Chaturvedi, et al.
Published: (2017-01-01)

Low risk of recurrence following artesunate–Sulphadoxine–pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan
by: Muzamil Mahdi Abdel Hamid, et al.
Published: (2018-03-01)

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria
by: Bose Carl, et al.
Published: (2011-05-01)

Delayed <it>Plasmodium falciparum</it> clearance following artesunate-mefloquine combination therapy in Thailand, 1997–2007
by: Vijaykadga Saowanit, et al.
Published: (2012-08-01)

Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.
by: Seif Shekalaghe, et al.
Published: (2007-10-01)

Dynamic RNA profiling in <it>Plasmodium falciparum </it>synchronized blood stages exposed to lethal doses of artesunate
by: Natalang Onguma, et al.
Published: (2008-08-01)